Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$TRAB DD Notes ~ http://www.ddnotesmaker.com/TRAB
ddnotesmaker.com
remove forum tags
$TRAB recent news/filings
## source: finance.yahoo.com
no recent news found
*********************************************************
$TRAB charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TRAB company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TRAB/company-info
Ticker: $TRAB
OTC Market Place: OTC Pink No Information
CIK code: 0001405286
Company name: TheraBiogen Inc.
Company website: http://www.theramaxrelief.com
Incorporated In: NV, USA
Business Description: TheraBiogen, Inc. is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market.
$TRAB share structure
## source: otcmarkets.com
Market Value: $75,163 a/o Jan 30, 2015
Shares Outstanding: 75,162,810 a/o Oct 31, 2014
Float: 19,000,000 a/o Jun 17, 2011
Authorized Shares: 150,000,000 a/o Jun 17, 2011
Par Value: No Par Value
$TRAB extra dd links
Company name: TheraBiogen Inc.
Company website: http://www.theramaxrelief.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TRAB+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TRAB+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TRAB+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TRAB/news - http://finance.yahoo.com/q/h?s=TRAB+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TRAB/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TRAB/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TRAB+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TRAB
DTCC (dtcc.com): http://search2.dtcc.com/?q=TheraBiogen+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=TheraBiogen+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=TheraBiogen+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.theramaxrelief.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.theramaxrelief.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.theramaxrelief.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TRAB
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001405286&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TRAB/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TRAB/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TRAB&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TRAB
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TRAB/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TRAB+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TRAB+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TRAB
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TRAB
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TRAB+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TRAB/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TRAB+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TRAB.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TRAB
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TRAB/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TRAB/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TRAB
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TRAB
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TRAB:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TRAB
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TRAB
$TRAB DD Notes ~ http://www.ddnotesmaker.com/TRAB
$$ GOSY $$ PROVIDES ANSWERS TO NISSAN'S AUTONOMOUS CAR ISSUES WITH GECKONAV(TM)
NISSANS WORKING WITH NASA FOR AUTONOMOUS TECHNOLOGY FOR MARS
HBRM- FREEMONEY =D
[img]
http://d13pix9kaak6wt.cloudfront.net/background/dragnes_1350064800_06.png[/img]
Management’s Discussion of Quarterly Report
For Quarter Ending August 31, 2014
Plan of Operations:
The Company plans to continue increasing market share and revenue from
AcnEase®, the Company’s all botanical acne treatment, through a number of
e-commerce initiatives and traditional distribution.
To support this objective, in the 3nd quarter of 2014, the Company deployed
a number of aggressive social media events and tactics including blog
initiatives in France, upgrading its French and Spanish content, and social
media outreach programs in the USA and Canada. The Company hired a native
French Social Media Marketing Specialist and a Content Writer to further
support the above initiatives. The Company also signed an agreement to
commence e-commerce commercialization of Herborium’s unique sexual
enhancement formulas Lasting Power® and Lasting Pleasure®.
FANTASTIC NEWS JUST HIT THE WIRES http://www.otcmarkets.com/stock/GOSY/news $$ GOSY $$
GOSY sounds good. -Sunny$$
$$ GOSY HIGHEST VOLUME OF THE YEAR. !$!$!$
$$ GOSY $$ FTW.
TOMORROWS PLAY GOSY GOSY GOSY
MY NEXT EPIC PLAY ~~>> $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY $GOSY
$$ GOSY $$ TOP PLAY $$
STOA ADDED TO THE LIST
NEW WINNERS TO LOAD BEFORE BOOM SAUCE
$$ GOSY $$ AND $$ FWDG $$
$PLGC DD Notes ~ http://www.ddnotesmaker.com/PLGC
ddnotesmaker.com
remove forum tags
$PLGC recent news/filings
## source: finance.yahoo.com
no recent news found
*********************************************************
$PLGC charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$PLGC company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/PLGC/company-info
Ticker: $PLGC
OTC Market Place: OTC Pink No Information
CIK code: 0001141590
Company name: Playlogic Entertainment, Inc.
Incorporated In: DE, USA
Business Description:
$PLGC share structure
## source: otcmarkets.com
Market Value: $48,555 a/o Jan 23, 2015
Shares Outstanding: 44,141,275 a/o Jun 30, 2008
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$PLGC extra dd links
Company name: Playlogic Entertainment, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PLGC+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PLGC+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PLGC+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PLGC/news - http://finance.yahoo.com/q/h?s=PLGC+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PLGC/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PLGC/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PLGC+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PLGC
DTCC (dtcc.com): http://search2.dtcc.com/?q=Playlogic+Entertainment%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Playlogic+Entertainment%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Playlogic+Entertainment%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PLGC
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001141590&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PLGC/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PLGC/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PLGC&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PLGC
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PLGC/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PLGC+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PLGC+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PLGC
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PLGC
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PLGC+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PLGC/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PLGC+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PLGC.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PLGC
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PLGC/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PLGC/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PLGC
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PLGC
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PLGC:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PLGC
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PLGC
$PLGC DD Notes ~ http://www.ddnotesmaker.com/PLGC
$$ FREEMONEY $$ LOADING $$ HPTG $$ FTW
$$ DCGD $$ FTW $$
WE HAVE A WINNER $$ DONALD TRUMP FTW $$ http://t.co/Yi7hJE1B0e SERIOUSLY CONSIDERING RUNNING FOR THE PRESIDENT OF THE UNITED STATES !$!$!$
Last email from IR here:
NS -- AV:
Hello friends and shareholders,
First and foremost, I am handing you my hat in hand, with an apology for delays and let you know things are looking great. Fortunately being we are full SEC reporting we have to make sure all paperwork is fully compliant with Finra filings requirements.
We are working overtime to insure this is done properly the first time. We have learned from the past how paperwork can affect everything, like the DTC/CEDE transfer issues because of paperwork not being a filed in late 2012.
Yes this is the basic root cause for the brokerage clearing issue we have experienced.
We have found a great new partner in our relationship with Pacific Stock Transfer and their various assets of the well informed staff they employ.
Between Susanne, Brooks and Matt, we have located the source and solution to our DTC issues.
We are correcting those issues right now.
With Suzy's knowledge and skills, we now are filing all the correct paperwork and corporate actions with Finra, the SEC, DTC/CEDE and having Pacific file a form after that. This is a process that was just a matter of one or two forms not filed almost two years ago.
At the same time we are preparing a corporate action for Finra and Sec approval. This will move us toward news.
We are taking the extra time to insure that the news coming by midweek, all is correctly filed and vetted.
Between our great new partners and the boards great experience, we are insuring everything is filed correctly the first time.
I do know this is pushing the patience level, but all filings we make are audited.
We have to be audit compliant for the companies future and all filings brought on also have to be audited.
This vetting process is almost complete at this time and this us the last step for the two boards to move the LOI to a new company.
I have been promised and I am promising we will have news to share by Wednesday 1/28 or sooner.
I can tell you, I am so ready to share but, I can not till all is legal.
Below is an earlier email I wrote one frustrated night and I had to resend it tonight.
Thank you from Steven Baritz, Leonardo Genovese and myself for enduring this painfully seeming long process toward building long term revenues for equity.
David Pecoraro
Net Savings and Global Distribution
814-418-6648
Please feel free to text, email or call I am here fir you all
FOFU WAS A FANTASTIC PLAY $$ FREEMONEY $$ OFF TILL NEXT WEEK HAVE A GREAT FRIDAY AND WEEKEND ALL :)
$$ FREEMONEY $$ OUTRO
SUTI NO BUYING PRESSURE I DECIDED NOT TO PLAY
$$ SUTI $$ NEXT STARBUCKS OF CANNABIS $$ http://www.otcmarkets.com/stock/SUTI/news/Company-introduces-a-new-Direction--business-plan-and-future-market-development?id=95640
5-10 BAGGER IMMINENT $$ FREEMONEY 4 ALL $$
$$ FOFU $$ BOB #4 board marks rising
EPIC PLAY FOR TOMORROW FOLKS BUCKLE UP $$ FREEMONEY $$ FTW $$
$$ FREEMONEY $$ DONE FOR THE DAY !$!$!$ $$ COOKIES BITCHES $$
SUGO PPCH HBRM AJAX FTW
MARCUS WILL RETURN TO OREGON 1 MORE YEAR DD ...
HES TOO COOKY FOR MEEEE
MONEYMADE IS BLAH !!!!!
@__FREEMONEY__: $$ FREEMONEY Predicts Marcus Mariota returns for his senior season $$
lob you called it!
WEEEEE GO DUCKS BOOOOOOM !$!$!$
FREEMONEY GIVING YOU 3 WINNERS HBRM POCH SUGO FREEMONEY FTW
GO DUCKS BOOOOM 7-0
EPICLY HOT MERGER PLAY $$ SUGO $$ I STOLE SOME CHEAPS TODAY ADDING MORE TOMORROW IMMINENT 5-10+ BAGGER
OREGON WINS IN A LAND SLIDE $$ FREEMONEY PREDICTS $$
$$ AJAC $$ ON FIRE CC MJ BOOOOM $$
THANKS MY FRIEND
Welcome back FREEMONEY.
LOB BABY $$ FREEMONEY $$
Going lightspeed ahead !!!
MM CAN YOU SEE ME NOW !$!$!$!$ THE ONLY ONE GRINDING $$ FREEMONEY FTW $$ PPCH $$
+>>>PPCH: News Out - Bio-Tech Company with Groundbreaking Technology; Propanc Health Group Has Unique Anti-Metastasic Drug
M2 Communications "M2 PressWIRE"
Friday, January 09 2015 6:36 AM, EST
Propanc Health Group Corp. , a biopharmaceutical company organized in Melbourne, Australia , in 2007, has developed a unique drug for the treatment of many types of cancer specifically targeting the process of metastasis. Targeted therapies for metastatic cancer has long been regarded as an important goal in cancer research, as metastasis is the cause of most cancer-related deaths and as no currently approved cancer therapies target metastasis.
Most types of cancer - specifically those that initially arise as solid tumors - develop over long periods of time, remaining non-malignant or at least relatively treatable if identified at this early stage. Cancer becomes far more serious and difficult to treat when it spreads to new locations within the body. This process, called metastasis, is dangerous for a number of reasons. For one, it leads to the establishment of tumors in organs where simple surgical removal may not be possible. Tumors that begin in the skin, for example, can be easily removed if caught early, but metastases that end up in the lungs or the brain or a nywhere near a large blood vessel can be dangerous to approach surgically.
Even more importantly, once a tumor has been found to spread to one site, it has very likely spread to many sites already. In these cases, simple surgical removal of one of the metastatic tumor is not nearly enough to deal with the spread. And metastatic tumors are often difficult to define clearly - tumors that start out as well-defined lumps are often diffuse and deeply integrated into the tissue when they are metastatic, again making them hard to approach surgically.
Finally, metastatic tumors have other qualities that make them more dangerous than primary tumors. Tumors that arise in skin, for example, maintain some of the qualities of skin cells for a time, but if they progress toward metastasis, they have typically acquired the qualities of the less well defined cells that normally live in places below the skin or below the surfaces of organs called mesenchymal cells. This transition from the qualities of epithelial (skin-like) cells to mesenchymal cells, also referred to as an epithelial to mesenchymal transition (EMT), has long been recognized as a general feature of the development of many types of cancer. Scientists have documented characteristic changes in the surfaces of these cells that are associated with the epithelial to mesenchymal transition, which includes the loss of a protein that normally allows these cells to stick tightly together, as in skin. This molecule, called E-cadherin, is a normal part of all skin cells and many other cell types that line the surfaces of organs.
Propanc has developed a blend of naturally-occurring chemicals - PRP - that has now been shown to specifically block or reverse the processes that lead to the development of metastases and their ability to grow and spread further. These chemicals, or proenzymes, are normally manufactured by the pancreas. In fact, the company name Propanc is derived from the words "proenzyme" and "pancreas". In tests on cancer cells, PRP was able to halt the growth of cancer cells and cause these cells to undergo cell death. It was also able to reverse the process of epithelial to mesenchymal transition, as indicated by specific changes in the proteins made by these cells, including the critical protein E-cadherin. Finally, PRP was also able to cause malignant cancer ce lls to transition to more harmless cell types, no longer cancerous. All three of these changes in cancer cells caused by PRP indicate that PRP may be highly effective in the treatment of metastatic cancers of many types. The results of these studies have been published in the peer-reviewed scientific journal Cellular Oncology in July, 2013.
What makes these findings particularly important is that there are currently no FDA -approved drugs specifically targeting metastatic cancer, yet without metastasis, most cancers would not be serious or fatal. Most chemical and radiological therapies for cancer are nonspecific, targeting all growing cells and therefore limiting their usefulness due to the inherent toxicity to normal cells. The demand for more targeted and less toxic drugs that specifically target metastasis is therefore enormous. Propanc has tremendous potential to change this market upon approval of PRP. It not only specifically targets metastatic cancer cells and the process of metastasis, it is composed of chemicals naturall y occurring in the human body and therefore lacking intrinsic toxicity to humans. This means that PRP could be used in a very high dose range, as needed for maximum effectiveness. It would also be less likely to exhibit toxic interactions when used in combination with other drugs.
The anti-tumor action of PRP can also be enhanced through the use of adjuncts that further enhance the tumor-killing properties of PRP. The Propanc formulation PRP-DCM adds well-studied chemotherapeutic agents that help to starve tumors of oxygen and increase the rate at which they undergo cell death.
Propanc is a forward-looking company that seeks to answer the large and growing demand for affordable, accessible, and easy to administer anti-cancer therapies. Propanc has developed a targeted anticancer therapeutic with the potential to extend survival among those patients with more advanced forms of cancer involving metastasis; currently, there are no drugs approved for the targeting of metastatic cancer, placing Propanc in a strong position as the regulatory process moves forward.
As a sector of the anti-cancer market, drugs targeting metastasis have not yet matured, and investors are not yet aware of its central importance for cancer therapy and its growth potential. Therefore, Propanc is currently likely to be highly undervalued as an investment.
Similar Companies to Propanc Health Group Corp. ( PPCH ) that are listed on major exchanges include:
Pluristem Therapeutics Inc. is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.
AEterna Zentaris Inc. is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The Company's pipeline encompasses compounds at various stages of development.
CTI BioPharma Corp. is a biopharmaceutical company whose mission is to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer.
About regalconsultingllc.com
RegalConsultingLLC.com is a leading independent research, advisory and consulting firm serving Investors, Publicly Traded Companies, Private Companies and The Financial Community .
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Regal Consulting , www.RegalConsultingLLC.com is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Regal Consulting, LLC . which owns www.RegalConsultingLLC.com may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Regal Consulting, LLC . which may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Media Contact
Company Name: RegalConsultingLLC.com
Contact Person: Media Relations
Email: RegalConsutlingLLC@gmail.com
Phone: 702-575-9157
Country: United States
Website: http://regalconsultingllc.com/
$$ PPCH $$ MONSTER IN THE MAKING $$ FREEMONEY $$
Followers
|
28
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
550
|
Created
|
07/06/14
|
Type
|
Premium
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |